Merck’s executives believe spinning off women’s health, biosimilars and legacy brands will allow the company to focus on higher-value endeavors, such as its growing oncology portfolio. (Merck). Share Facebook Twitter LinkedIn Email Print. If one word could …
See Original Article

Terror, climate change and Brexit. Bloomberg Opinion columnist Therese Raphael joins Bloomberg Westminster's Caroline Hepker and Sebastian
See Original Article

news@thelocal.it · @thelocalitaly. 5 February 2020. 15:55 CET+01:00. On World Nutella Day, we look at the unusual and sometimes controversial history of Italy’s famous hazelnut spread. In 1964, the first jar of what we now call Nutella was sold from a bakery …
See Original Article

Jay Jacobs, Head:Research & Strategy, Global X Management Company, joined Bryan Curtis and Kathleen Hays on Daybreak Asia. He says
See Original Article

Gilead Sciences (NASDAQ: GILD) reported fourth-quarter and full-year results after the closing bell Tuesday. Investors were none too pleased with the big biotech’s financial results or near-term outlook. Immediately after disclosing its latest financial figures, …
See Original Article